我们应用血脂康对42例原发性高脂血症患者进行了临床疗效观察,其结果报告如下。 一、资料与方法 1.病例选择:近4周内未服用其他降血脂药物的门诊或住院高脂血症患者,删除半年内曾患心肌梗死、脑血管意外、严重创伤或重大手术者、肾病综合征、甲减、急性或慢性肝胆疾病,糖尿病及痛风、纯合子家族性高胆固醇血症、由药物引起的高脂血症。 We applied Xuezhikan 42 cases of primary hyperlipidemia in patients with clinical efficacy, the results are reported as follows. First, the data and methods 1. Case Selection: In the past 4 weeks did not take other anti-hyperlipidemic drugs outpatient or hospitalized patients with hyperlipidemia, deleted within six months had myocardial infarction, cerebrovascular accident, severe trauma or major surgery, kidney disease Syndrome, hypothyroidism, acute or chronic hepatobiliary disease, diabetes and gout, homozygous familial hypercholesterolemia, hyperlipidemia caused by the drug.